Lajos Pusztai
Lajos Pusztai
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
C Liedtke, C Mazouni, KR Hess, F André, A Tordai, JA Mejia, ...
Journal of clinical oncology 26 (8), 1275-1281, 2008
24182008
The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements
L Shi, LH Reid, WD Jones, R Shippy, JA Warrington, SC Baker, PJ Collins, ...
Nature biotechnology 24 (9), 1151, 2006
21612006
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier, CM Perou, WF Symmans, N Ibrahim, M Cristofanilli, ...
Clinical cancer research 11 (16), 5678-5685, 2005
21292005
Gene-expression signatures in breast cancer
C Sotiriou, L Pusztai
New England Journal of Medicine 360 (8), 790-800, 2009
16132009
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ...
Nature biotechnology 31 (11), 1023-1031, 2013
12422013
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in …
AU Buzdar, NK Ibrahim, D Francis, DJ Booser, ES Thomas, RL Theriault, ...
Journal of clinical oncology 23 (16), 3676-3685, 2005
12302005
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
J Baselga, I Bradbury, H Eidtmann, S Di Cosimo, E De Azambuja, C Aura, ...
The Lancet 379 (9816), 633-640, 2012
11792012
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine
JS Ross, EA Slodkowska, WF Symmans, L Pusztai, PM Ravdin, ...
Oncologist 14 (4), 320, 2009
10562009
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy
WF Symmans, F Peintinger, C Hatzis, R Rajan, H Kuerer, V Valero, ...
Journal of Clinical Oncology 25 (28), 4414-4422, 2007
9742007
An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
K Stemke-Hale, AM Gonzalez-Angulo, A Lluch, RM Neve, WL Kuo, ...
Cancer research 68 (15), 6084-6091, 2008
9202008
The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy
JS Ross, JA Fletcher, GP Linette, J Stec, E Clark, M Ayers, WF Symmans, ...
Oncologist 8 (4), 307-325, 2003
7992003
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
KR Hess, K Anderson, WF Symmans, V Valero, N Ibrahim, JA Mejia, ...
Journal of clinical oncology 24 (26), 4236-4244, 2006
7432006
Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study
R Nanda, LQM Chow, EC Dees, R Berger, S Gupta, R Geva, L Pusztai, ...
Journal of Clinical Oncology 34 (21), 2460, 2016
7082016
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2–overexpressing metastatic breast cancer
FJ Esteva, V Valero, D Booser, LT Guerra, JL Murray, L Pusztai, ...
Journal of Clinical Oncology 20 (7), 1800-1808, 2002
6852002
Gene expression profiling in breast cancer: classification, prognostication, and prediction
JS Reis-Filho, L Pusztai
The Lancet 378 (9805), 1812-1823, 2011
6592011
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
MaQC Consortium
Nature biotechnology 28 (8), 827, 2010
6482010
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer
M Ayers, WF Symmans, J Stec, AI Damokosh, E Clark, K Hess, M Lecocke, ...
Journal of clinical oncology 22 (12), 2284-2293, 2004
6162004
Cancer heterogeneity: implications for targeted therapeutics
R Fisher, L Pusztai, C Swanton
British journal of cancer 108 (3), 479-485, 2013
6122013
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni, M Zambetti, K Clark, J Baker, M Cronin, J Wu, G Mariani, ...
Journal of clinical oncology 23 (29), 7265-7277, 2005
5782005
Triple-negative breast cancer—current status and future directions
O Gluz, C Liedtke, N Gottschalk, L Pusztai, U Nitz, N Harbeck
Annals of Oncology 20 (12), 1913-1927, 2009
5402009
The system can't perform the operation now. Try again later.
Articles 1–20